At a glance
ClinicalIndex Comparison RecordN/ACompleted· 194 enrolled
Drug / intervention
noninvasively Bio-electrical Impedance Analysis (BIA)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Application of Serial Body Composition Change for Risk Prediction in Treating Patients With Severe Pneumonia
In Brief
An observational study evaluating noninvasively Bio-electrical Impedance Analysis (BIA) for Pneumonia. Completed, enrolled 194 participants across 1 site.
Detailed Summary
We hypothesize that serial changes of body composition in patients with pneumonia can help clinician to monitor prognosis. It was associated with underlying immune response.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPneumonia
CountriesTaiwan
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartMay 2019
First PostedMay 2020
Primary CompletionJan 2023
Study CompletionFeb 2023
TodayJul 2026
First PostedMay 20, 2020
Enrollment StartMay 1, 2019
Primary CompletionJan 9, 2023
Study CompletionFeb 21, 2023
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 6.1 years ago
Interventions
noninvasively Bio-electrical Impedance Analysis (BIA)device
By means of noninvasively Bio-electrical Impedance Analysis (BIA) to measure body composition, which divides body weight into different components such as lean body mass and fat mass.